Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
International public health

India Hepatitis Elimination Pledge at UNGA 81

Analysis based on 6 articles · First reported Sep 23, 2026 · Last updated Sep 23, 2026

Sentiment
5
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The reaffirmed hepatitis elimination commitment and the CDSCO advisory on NSAIDs and antibiotics signal continued tightening of India's pharmaceutical regulation, which could modestly affect sales volumes for over-the-counter painkiller and antibiotic makers while supporting demand for diagnostics, antivirals and hepatitis screening programs. Overall market impact is limited and largely confined to Indian pharma and healthcare names, with no broad macroeconomic or cross-asset implications.

pharmaceuticals healthcare

At a side event of the 81st session of the International — United Nations General Assembly titled Advancing Global Action to Eliminate Hepatitis, organized by the UN Group of Friends to Eliminate Hepatitis, Union Health Secretary Punya Salila Srivastava reaffirmed India's commitment to the 2030 Sustainable Development Goals agenda on combating Hepatitis and to the global target of eliminating Hepatitis B and C as public health threats by 2030. According to the Bangladesh — Ministry of Health and Family Welfare, India's approach is people-centred and spans prevention, screening, diagnosis, treatment and care, aimed at reducing the disease burden through early detection and treatment. In a separate development, the India — Central Drugs Standard Control Organisation issued an advisory circular, dated September 21, to healthcare professionals, pharmacists, retailers, distributors, hospitals and the general public warning against the indiscriminate use of painkillers, particularly Non-Steroidal Anti-Inflammatory Drugs, and antibiotics, citing associated risks of Chronic Kidney Disease. According to the India — Directorate General of Health Services, such drugs should only be used when clinically indicated, in appropriate doses and for the recommended duration, under the supervision of a Registered Medical Practitioner. The circular noted that most NSAIDs fall under Schedule H of the Drugs Rules, 1945 and cannot be sold at retail without prescription, while most antibiotics fall under Schedule H1 and must carry specific warnings, with import, manufacturing, sale and distribution regulated under the Drugs and Cosmetics Act, 1940.

cnt
India reaffirmed its commitment to eliminate Hepatitis B and C as public health threats by 2030 and its drug regulator issued a new advisory on painkillers and antibiotics, shaping the domestic pharmaceutical regulatory environment.
Importance 90.0 Sentiment 10.0
per
As Union Health Secretary she reaffirmed India's commitment to eliminating Hepatitis B and C by 2030 and outlined the country's people-centred prevention and treatment strategy.
Importance 60.0 Sentiment 5.0
govactor
It issued an advisory circular against indiscriminate use of NSAIDs and antibiotics over Chronic Kidney Disease risks, potentially curbing unregulated sales of these drugs in India.
Importance 55.0 Sentiment -5.0
govactor
It is the ministry whose stated position underpins India's hepatitis elimination commitment and public health strategy highlighted at the UNGA side event.
Importance 50.0 Sentiment 5.0
govactor
Its 81st session hosted the side event where India presented its hepatitis elimination approach, providing the international platform for the commitment.
Importance 40.0 Sentiment 5.0
govactor
It provided the regulatory details behind the advisory, noting that NSAIDs and antibiotics fall under Schedules H and H1 of the Drugs Rules, 1945 and require prescriptions and warnings.
Importance 35.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.